MEMRI in HFpEF

  • Research type

    Research Study

  • Full title

    Manganese-enhanced magnetic resonance imaging in patients with heart failure with preserved ejection fraction

  • IRAS ID

    322114

  • Contact name

    Gerry McCann

  • Contact email

    gpm12@leicester.ac.uk

  • Sponsor organisation

    University of Leicester

  • Duration of Study in the UK

    12 years, 0 months, 1 days

  • Research summary

    Heart failure with preserved ejection fraction (HFpEF) is condition in which the heart cannot fill with blood effectively. As a result, people with HFpEF suffer fatigue, breathlessness, and develop swollen limbs. The condition often requires multiple admissions to hospital and is associated with a marked loss of lifespan.

    Despite being so common, very little is known about why people develop HFpEF and there are hardly any known treatments. Type 2 diabetes (T2D) is a major risk factor for HFpEF, and people with both HFpEF and diabetes are at a heightened risk of hospitalisation and premature death. It is unclear why the combination of diabetes and HFpEF is particularly harmful. This may be related to the hearts of people with type 2 diabetes being unable to take up the mineral calcium properly, as well as due to their hearts being less energy efficient. Both of these are vital to heart muscle pumping and filling, but until recently it has not been possible to assess these in humans.

    New advances in heart MRI scans, with dedicated scanner techniques and dyes (manganese contrast), now allow us to take extremely detailed pictures of heart structure, function, calcium uptake and energy efficiency, all during the same scan. We will enlist 40 volunteers with HFpEF (20 with T2D and 20 without T2D), and up to 20 healthy volunteers, to undergo a heart MRI scan with manganese contrast to assess calcium uptake and energy efficiency. This will help us compare people with HFpEF with and without T2D, to see how their hearts are different to healthy volunteers.

  • REC name

    South Central - Berkshire B Research Ethics Committee

  • REC reference

    23/SC/0037

  • Date of REC Opinion

    10 Mar 2023

  • REC opinion

    Further Information Favourable Opinion